Adage Capital Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

Adage Capital Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28,571	Closed	-$527K	–	1067
2020 Q4	$527K	Hold	28,571	–	–	﹤0.01%	789
2020 Q3	$1.62M	Hold	28,571	–	–	﹤0.01%	711
2020 Q2	$856K	Hold	28,571	–	–	﹤0.01%	707
2020 Q1	$562K	Hold	28,571	–	–	﹤0.01%	697
2019 Q4	$1.52M	Hold	28,571	–	–	﹤0.01%	668
2019 Q3	$1.56M	Hold	28,571	–	–	﹤0.01%	670
2019 Q2	$3.27M	Hold	28,571	–	–	0.01%	645
2019 Q1	$4.77M	Hold	28,571	–	–	0.01%	607
2018 Q4	$2.12M	Hold	28,571	–	–	0.01%	662
2018 Q3	$4.09M	Hold	28,571	–	–	0.01%	649
2018 Q2	$4.08M	Hold	28,571	–	–	0.01%	662
2018 Q1	$5.04M	Buy	+28,571	New	+$9.56M	0.01%	642

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Adage Capital Partners's ZSAN Position: Q1 2021 in Review

Adage Capital Partners sold out of Zosano Pharma Corporation (ZSAN) in Q1 2021, closing a stake of 28,571 shares — an estimated $527K sold.

Adage Capital Partners first reported a position in ZSAN in Q1 2018 and held it in 12 quarters. The position peaked at $5.04M in Q1 2018. 35 funds tracked by Wall St. Rank hold ZSAN as of Q1 2021.

Adage Capital Partners reported no remaining Zosano Pharma Corporation position as of Q1 2021 after selling out during the quarter.
Adage Capital Partners sold 28,571 Zosano Pharma Corporation shares in Q1 2021, an estimated $527K.
Adage Capital Partners first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 12 quarters.
Adage Capital Partners's Zosano Pharma Corporation position peaked at $5.04M in Q1 2018.
35 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2021.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.